Peptides targeting receptor activator of nuclear factor-κB (RANK) and their applications

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9403873
APP PUB NO 20140371150A1
SERIAL NO

14368080

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a polypeptide for use as a medicament in the treatment and/or prevention of a disease wherein the RANKL-RANK signaling pathway is involved, in particular a bone resorptive disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITE DE NANTES1 QUAI DE TOURVILLE NANTES 44000
CHU NANTES44000 NANTES

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Heymann, Dominique Indre, FR 5 7
Stresing, Verena Nantes, FR 1 0
Teletchea, Stéphane Bouguenais, FR 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 2, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00